![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
This article has been cited by other articles:
|
|
 |
|
  J. D. Urban, W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Breit, K. Wolff, H. Kalwa, H. Jarry, T. Buch, and T. Gudermann The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors J. Biol. Chem., December 8, 2006; 281(49): 37447 - 37456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ginj, H. Zhang, B. Waser, R. Cescato, D. Wild, X. Wang, J. Erchegyi, J. Rivier, H. R. Macke, and J. C. Reubi Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors PNAS, October 31, 2006; 103(44): 16436 - 16441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Jacquier, M. Prummer, J.-M. Segura, H. Pick, and H. Vogel Visualizing odorant receptor trafficking in living cells down to the single-molecule level PNAS, September 26, 2006; 103(39): 14325 - 14330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Saita, E. Kodama, M. Orita, M. Kondo, T. Miyazaki, K. Sudo, K. Kajiwara, M. Matsuoka, and Y. Shimizu Structural Basis for the Interaction of CCR5 with a Small Molecule, Functionally Selective CCR5 Agonist. J. Immunol., September 1, 2006; 177(5): 3116 - 3122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, G. R. Dubyak, M. M. Lederman, and A. Weinberg Cutting Edge: Human beta Defensin 3--A Novel Antagonist of the HIV-1 Coreceptor CXCR4 J. Immunol., July 15, 2006; 177(2): 782 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kenakin Receptors as Microprocessors: Pharmacological Nuance on Metabotropic Glutamate Receptors 1{alpha} Sci. Signal., July 3, 2006; 2006(342): pe29 - pe29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Cescato, S. Schulz, B. Waser, V. Eltschinger, J. E. Rivier, H.-J. Wester, M. Culler, M. Ginj, Q. Liu, A. Schonbrunn, et al. Internalization of sst2, sst3, and sst5 Receptors: Effects of Somatostatin Agonists and Antagonists J. Nucl. Med., March 1, 2006; 47(3): 502 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Milasta, J. Pediani, S. Appelbe, S. Trim, M. Wyatt, P. Cox, M. Fidock, and G. Milligan Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD Mol. Pharmacol., February 1, 2006; 69(2): 479 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Nelson, S. R. Nahorski, and R. A. J. Challiss Constitutive Activity and Inverse Agonism at the M2 Muscarinic Acetylcholine Receptor J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 279 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Maudsley, B. Martin, and L. M. Luttrell The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 485 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Liu, R. Cescato, D. A. Dewi, J. Rivier, J.-C. Reubi, and A. Schonbrunn Receptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin Analogs Mol. Pharmacol., July 1, 2005; 68(1): 90 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Perez and S. S. Karnik Multiple Signaling States of G-Protein-Coupled Receptors Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Nickolls, B. Fleck, S. R. J. Hoare, and R. A. Maki Functional Selectivity of Melanocortin 4 Receptor Peptide and Nonpeptide Agonists: Evidence for Ligand-Specific Conformational States J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1281 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. Clarke What's for Lunch at the Conformational Cafeteria? Mol. Pharmacol., June 1, 2005; 67(6): 1819 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Pediani, J. F. Colston, D. Caldwell, G. Milligan, C. J. Daly, and J. C. McGrath {beta}-Arrestin-Dependent Spontaneous {alpha}1a-Adrenoceptor Endocytosis Causes Intracellular Transportation of {alpha}-Blockers via Recycling Compartments Mol. Pharmacol., April 1, 2005; 67(4): 992 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Audet, M. Paquin-Gobeil, O. Landry-Paquet, P. W. Schiller, and G. Pineyro Internalization and Src Activity Regulate the Time Course of ERK Activation by Delta Opioid Receptor Ligands J. Biol. Chem., March 4, 2005; 280(9): 7808 - 7816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bhattacharya, A. V. Babwah, C. Godin, P. H. Anborgh, L. B. Dale, M. O. Poulter, and S. S. G. Ferguson Ral and Phospholipase D2-Dependent Pathway for Constitutive Metabotropic Glutamate Receptor Endocytosis J. Neurosci., October 6, 2004; 24(40): 8752 - 8761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Morris, R. R. Price, M. P. Smith, B. Lei, and D. A. Schwinn Cellular Trafficking of Human {alpha}1a-Adrenergic Receptors Is Continuous and Primarily Agonist-Independent Mol. Pharmacol., October 1, 2004; 66(4): 843 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wietfeld, N. Heinrich, J. Furkert, K. Fechner, M. Beyermann, M. Bienert, and H. Berger Regulation of the Coupling to Different G Proteins of Rat Corticotropin-releasing Factor Receptor Type 1 in Human Embryonic Kidney 293 Cells J. Biol. Chem., September 10, 2004; 279(37): 38386 - 38394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Schlag, Z. Lou, M. Fennell, and J. Dunlop Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bisello, D. Manen, D. D. Pierroz, T. B. Usdin, R. Rizzoli, and S. L. Ferrari Agonist-Specific Regulation of Parathyroid Hormone (PTH) Receptor Type 2 Activity: Structural and Functional Analysis of PTH- and Tuberoinfundibular Peptide (TIP) 39-Stimulated Desensitization and Internalization Mol. Endocrinol., June 1, 2004; 18(6): 1486 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Dupre, C. Le Gouill, D. Gingras, M. Rola-Pleszczynski, and J. Stankova Inverse Agonist Activity of Selected Ligands of the Cysteinyl-Leukotriene Receptor 1 J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 102 - 108. [Abstract] [Full Text]
|
|
|
|
|
|
W. B. Sneddon, C. A. Syme, A. Bisello, C. E. Magyar, M. D. Rochdi, J.-L. Parent, E. J. Weinman, A. B. Abou-Samra, and P. A. Friedman Activation-independent Parathyroid Hormone Receptor Internalization Is Regulated by NHERF1 (EBP50) J. Biol. Chem., October 31, 2003; 278(44): 43787 - 43796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Borgland, M. Connor, P. B. Osborne, J. B. Furness, and M. J. Christie Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors J. Biol. Chem., May 23, 2003; 278(21): 18776 - 18784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz, A. Wehmeyer, and K. Schulz Visualizing Preference of G Protein-Coupled Receptor Kinase 3 for the Process of kappa -Opioid Receptor Sequestration Mol. Pharmacol., June 1, 2002; 61(6): 1444 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Harikumar, D. I. Pinon, W. S. Wessels, F. G. Prendergast, and L. J. Miller Environment and Mobility of a Series of Fluorescent Reporters at the Amino Terminus of Structurally Related Peptide Agonists and Antagonists Bound to the Cholecystokinin Receptor J. Biol. Chem., May 17, 2002; 277(21): 18552 - 18560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Q. Ding, D. I. Pinon, K. E. Furse, T. P. Lybrand, and L. J. Miller Refinement of the Conformation of a Critical Region of Charge-Charge Interaction between Cholecystokinin and Its Receptor Mol. Pharmacol., May 1, 2002; 61(5): 1041 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz, A. Wehmeyer, and K. Schulz Opioid Receptor Types Selectively Cointernalize with G Protein-Coupled Receptor Kinases 2 and 3 J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-J. Cheng and L. J. Miller Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer J. Biol. Chem., December 14, 2001; 276(51): 48040 - 48047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Dupre, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova Inverse Agonist Activity of Selected Ligands of Platelet-Activating Factor Receptor J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Q. Ding, R. V. Rao, S. M. Kuntz, E. L. Holicky, and L. J. Miller Impaired Resensitization and Recycling of the Cholecystokinin Receptor by Co-expression of its Second Intracellular Loop Mol. Pharmacol., April 13, 2001; 58(6): 1424 - 1433. [Abstract] [Full Text]
|
|
|
|
|
|
M. Waelbroeck Activation of Guanosine 5'-[{gamma}-35S]thio-triphosphate Binding through M1 Muscarinic Receptors in Transfected Chinese Hamster Ovary Cell Membranes: 2. Testing the "Two-States" Model of Receptor Activation Mol. Pharmacol., April 1, 2001; 59(4): 886 - 893. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. KENAKIN Inverse, protean, and ligand-selective agonism: matters of receptor conformation FASEB J, March 1, 2001; 15(3): 598 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. G. Ferguson Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling Pharmacol. Rev., March 1, 2001; 53(1): 1 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Rao, E. L. Holicky, S. M. Kuntz, and L. J. Miller CCK receptor phosphorylation exposes regulatory domains affecting phosphorylation and receptor trafficking Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1986 - C1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Zaki, D. E. Keith Jr., G. A. Brine, F. I. Carroll, and C. J. Evans Ligand-Induced Changes in Surface {micro}-Opioid Receptor Number: Relationship to G Protein Activation? J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1127 - 1134. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Ferrari, V. Behar, M. Chorev, M. Rosenblatt, and A. Bisello Endocytosis of Ligand-Human Parathyroid Hormone Receptor 1 Complexes Is Protein Kinase C-dependent and Involves beta -Arrestin2. REAL-TIME MONITORING BY FLUORESCENCE MICROSCOPY J. Biol. Chem., October 15, 1999; 274(42): 29968 - 29975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Seifert, U. Gether, K. Wenzel-Seifert, and B. K. Kobilka Effects of Guanine, Inosine, and Xanthine Nucleotides on beta 2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations Mol. Pharmacol., August 1, 1999; 56(2): 348 - 358. [Abstract] [Full Text]
|
|
|
|
|
|
R. Yu and P. M. Hinkle Signal Transduction and Hormone-dependent Internalization of the Thyrotropin-releasing Hormone Receptor in Cells Lacking Gq and G11 J. Biol. Chem., May 28, 1999; 274(22): 15745 - 15750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Wu, M. Yang, D. Avedian, M. Birnbaumer, and J. H. Walsh Single Amino Acid Substitution of Serine82 to Asparagine in First Intracellular Loop of Human Cholecystokinin (CCK)-B Receptor Confers Full Cyclic AMP Responses to CCK and Gastrin Mol. Pharmacol., May 1, 1999; 55(5): 795 - 803. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Berg, B. D. Stout, J. D. Cropper, S. Maayani, and W. P. Clarke Novel Actions of Inverse Agonists on 5-HT2C Receptor Systems Mol. Pharmacol., May 1, 1999; 55(5): 863 - 872. [Abstract] [Full Text]
|
|
|
|
|
|
J.-L. Parent, P. Labrecque, M. J. Orsini, and J. L. Benovic Internalization of the TXA2 Receptor alpha and beta Isoforms. ROLE OF THE DIFFERENTIALLY SPLICED COOH TERMINUS IN AGONIST-PROMOTED RECEPTOR INTERNALIZATION J. Biol. Chem., March 26, 1999; 274(13): 8941 - 8948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. del Valle CCK receptor trafficking: a novel paradigm of travel. Focus on "Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist" Am J Physiol Cell Physiol, March 1, 1999; 276(3): C537 - C538. [Full Text] [PDF]
|
|
|
|
|
|
B. F. Roettger, D. I. Pinon, T. P. Burghardt, and L. J. Miller Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist Am J Physiol Cell Physiol, March 1, 1999; 276(3): C539 - C547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dong, X.-Q. Ding, D. I. Pinon, E. M. Hadac, R. P. Oda, J. P. Landers, and L. J. Miller Structurally Related Peptide Agonist, Partial Agonist, and Antagonist Occupy a Similar Binding Pocket within the Cholecystokinin Receptor. RAPID ANALYSIS USING FLUORESCENT PHOTOAFFINITY LABELING PROBES AND CAPILLARY ELECTROPHORESIS J. Biol. Chem., February 19, 1999; 274(8): 4778 - 4785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Portier, M. Rinaldi-Carmona, F. Pecceu, T. Combes, C. Poinot-Chazel, B. Calandra, F. Barth, G. L. Fur, and P. Casellas SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 582 - 589. [Abstract] [Full Text]
|
|
|
|
|
|
O. Vögler, P. Krummenerl, M. Schmidt, K. H. Jakobs, and C. J. Van Koppen RhoA-Sensitive Trafficking of Muscarinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 36 - 42. [Abstract] [Full Text]
|
|
|
|
|
|
B. Y. Williams, S. B. Dion, and A. Schonbrunn Role of Receptor and Protein Kinase C Activation in the Internalization of the Gastrin-Releasing Peptide Receptor Mol. Pharmacol., November 1, 1998; 54(5): 889 - 898. [Abstract] [Full Text]
|
|
|
|
|
|
W. G. Thomas, T. J. Motel, C. E. Kule, V. Karoor, and K. M. Baker Phosphorylation of the Angiotensin II (AT1A) Receptor Carboxyl Terminus: A Role in Receptor Endocytosis Mol. Endocrinol., October 1, 1998; 12(10): 1513 - 1524. [Abstract] [Full Text]
|
|
|
|
|
|
T. Drmota, G. W. Gould, and G. Milligan Real Time Visualization of Agonist-mediated Redistribution and Internalization of a Green Fluorescent Protein-tagged Form of the Thyrotropin-releasing Hormone Receptor J. Biol. Chem., September 11, 1998; 273(37): 24000 - 24008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Drmota, J. Novotny, G.-D. Kim, K. A. Eidne, G. Milligan, and P. Svoboda Agonist-induced Internalization of the G Protein G11alpha and Thyrotropin-releasing Hormone Receptors Proceed on Different Time Scales J. Biol. Chem., August 21, 1998; 273(34): 21699 - 21707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hukovic, R. Panetta, U. Kumar, M. Rocheville, and Y. C. Patel The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization J. Biol. Chem., August 14, 1998; 273(33): 21416 - 21422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bhowmick, P. Narayan, and D. Puett The Endothelin Subtype A Receptor Undergoes Agonist- and Antagonist-Mediated Internalization in the Absence of Signaling Endocrinology, July 1, 1998; 139(7): 3185 - 3192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Sorensen, D. A. Linseman, E. L. McEwen, A. M. Heacock, and S. K. Fisher A Role for a Wortmannin-Sensitive Phosphatidylinositol-4-Kinase in the Endocytosis of Muscarinic Cholinergic Receptors Mol. Pharmacol., May 1, 1998; 53(5): 827 - 836. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Szekeres, J. A. Koenig, and J. M. Edwardson The Relationship between Agonist Intrinsic Activity and the Rate of Endocytosis of Muscarinic Receptors in a Human Neuroblastoma Cell Line Mol. Pharmacol., April 1, 1998; 53(4): 759 - 765. [Abstract] [Full Text]
|
|
|
|
|
|
R.-M. Lyu, P. M. Germano, J. K. Choi, S. V. Le, and J. R. Pisegna Identification of an Essential Amino Acid Motif within the C Terminus of the Pituitary Adenylate Cyclase-activating Polypeptide Type I Receptor That Is Critical for Signal Transduction but Not for Receptor Internalization J. Biol. Chem., November 10, 2000; 275(46): 36134 - 36142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Palanche, B. Ilien, S. Zoffmann, M.-P. Reck, B. Bucher, S. J. Edelstein, and J.-L. Galzi The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States J. Biol. Chem., September 7, 2001; 276(37): 34853 - 34861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Reubi, J.-C. Schaer, S. Wenger, C. Hoeger, J. Erchegyi, B. Waser, and J. Rivier SST3-selective potent peptidic somatostatin receptor antagonists PNAS, December 5, 2000; 97(25): 13973 - 13978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blanpain, J.-M. Vanderwinden, J. Cihak, V. Wittamer, E. Le Poul, H. Issafras, M. Stangassinger, G. Vassart, S. Marullo, D. Schlondorff, et al. Multiple Active States and Oligomerization of CCR5 Revealed by Functional Properties of Monoclonal Antibodies Mol. Biol. Cell, February 1, 2002; 13(2): 723 - 737. [Abstract] [Full Text] [PDF]
|
|
